Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-223796
Filing Date
2024-09-23
Accepted
2024-09-23 17:14:32
Documents
19
Effectiveness Date
2024-09-23

Document Format Files

Seq Description Document Type Size
1 S-8 d858620ds8.htm S-8 54562
2 EX-5.1 d858620dex51.htm EX-5.1 7560
3 EX-23.1 d858620dex231.htm EX-23.1 1720
4 EX-99.1 d858620dex991.htm EX-99.1 133522
5 EX-99.2 d858620dex992.htm EX-99.2 44798
6 EX-99.3 d858620dex993.htm EX-99.3 30767
7 EX-FILING FEES d858620dexfilingfees.htm   iXBRL EX-FILING FEES 42620
8 GRAPHIC g858620g0920011208659.jpg GRAPHIC 2233
  Complete submission text file 0001193125-24-223796.txt   452304

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT d858620dexfilingfees_htm.xml XML 6268
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-282295 | Film No.: 241316886
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)